Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11858907 Kinase modulators

Patent 11858907 was granted and assigned to Rhizen Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Rhizen Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Swaroop K. Vakkalanka0

Govindarajulu Babu0

Srikant Viswanadha0

Meyyappan Muthuppalaniappan0

Date of Patent

January 2, 2024

0

Patent Application Number

165575530

Date Filed

August 30, 2019

0

Patent Citations

US Patent 7589101 Compounds and compositions as protein kinase inhibitors

0

US Patent 7592342 Quinoxaline derivatives as PI3 kinase inhibitors

0

US Patent 7595320 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof

0

US Patent 7595330 Benzimidazole thiophene compounds

0

US Patent 7598245 Aminotriazole compounds useful as inhibitors of protein kinases

0

US Patent 7601718 Compositions useful as inhibitors of protein kinases

0

US Patent 7601724 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

0

US Patent 7605155 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

0

...

Patent Primary Examiner

Brian E McDowell

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11858907 Kinase modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool